Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site.

Squamous cell carcinoma of an unknown primary (SCCUP) of the head and neck is a rare disease. As a diagnosis of exclusion, the manner in which it is assigned merits consideration. Despite the development and refinement of several techniques designed to locate an occult tumor, including cross-sectional anatomic imaging, functional imaging, and transoral surgical techniques, delineating SCCUP remains an active clinical problem. Its relative rarity has prevented prospective study of the entity. Hence, investigators must rely on retrospective analyses to understand the disease and its appropriate treatment. The current understanding of SCCUP differs substantially from when it was initially described decades ago. The most common site of a small primary tumor initially thought to represent SCCUP is the tonsil or base of the tongue, and an increasing percentage are associated with human papilloma virus. Modern treatment of SCCUP by neck dissection alone, neck dissection followed by radiation with or without concurrent chemotherapy, or primary chemoradiation according to initial nodal disease burden produces extraordinarily low recurrence rates. Whether the potential mucosal primary site and/or the contralateral neck should be electively treated is controversial. Efficacy data seem to be similar; therefore, an evaluation of the toxicity of both treatment paradigms is warranted.

[1]  Jonathan R. Clark,et al.  Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system , 2016, Head & neck.

[2]  M. Zelefsky,et al.  Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy , 2014, Head & neck.

[3]  W. Thorstad,et al.  Management of human papillomavirus–related unknown primaries of the head and neck with a transoral surgical approach , 2015, Head & neck.

[4]  D. Flieder,et al.  p16 status, pathologic and clinical characteristics, biomolecular signature, and long‐term outcomes in head and neck squamous cell carcinomas of unknown primary , 2014, Head & neck.

[5]  M. Schipper,et al.  Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy , 2014, Head & neck.

[6]  P. Harari,et al.  p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Hayden,et al.  Transoral laser microsurgery for the unknown primary: Role for lingual tonsillectomy , 2014, Head & neck.

[8]  T. Teknos,et al.  Transoral robotic approach to carcinoma of unknown primary , 2014, Head & neck.

[9]  D. Flieder,et al.  HPV Association and the Increasing Incidence of Unknown Primary Head-and-Neck Squamous Cell Carcinoma : Epidemiology and Prevention , 2014 .

[10]  M. Urken,et al.  Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck. , 2014, Anticancer research.

[11]  Quynh-Thu Le,et al.  Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  E. Sturgis,et al.  p16 Expression in cutaneous squamous carcinomas with neck metastases: A potential pitfall in identifying unknown primaries of the head and neck , 2013, Head & neck.

[13]  E. Mendez,et al.  Robotic surgery for primary head and neck squamous cell carcinoma of unknown site. , 2013, JAMA otolaryngology-- head & neck surgery.

[14]  Wei Xu,et al.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Ferris,et al.  A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: A role for transoral robotic surgery , 2012, The Laryngoscope.

[16]  M. Yunus,et al.  Diagnosis and treatment of branchial cleft anomalies in UKMMC: a 10-year retrospective study , 2013, European Archives of Oto-Rhino-Laryngology.

[17]  D. Kallogjeri,et al.  Extracapsular spread and adjuvant therapy in human papillomavirus‐related, p16‐positive oropharyngeal carcinoma , 2012, Cancer.

[18]  W. Thorstad,et al.  Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. , 2012, Archives of otolaryngology--head & neck surgery.

[19]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  D. Farwell,et al.  Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? , 2011, International journal of radiation oncology, biology, physics.

[21]  R. Tishler,et al.  Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck. , 2011, International journal of radiation oncology, biology, physics.

[22]  P. Harari,et al.  Head and neck squamous cell carcinoma from an unknown primary site. , 2011, American journal of otolaryngology.

[23]  Tara N Moore-Medlin,et al.  Human Papillomavirus in Metastatic Lymph Nodes from Unknown Primary Head and Neck Squamous Cell Carcinoma , 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[24]  A. Garden,et al.  Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. , 2010, International Journal of Radiation Oncology, Biology, Physics.

[25]  W. Mendenhall,et al.  Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site , 2009, The Laryngoscope.

[26]  P. Maingon,et al.  Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  A. Jenson,et al.  Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study. , 2009, Experimental and molecular pathology.

[28]  D. Schuller,et al.  Tonsillectomy vs. deep tonsil biopsies in detecting occult tonsil tumors , 2009, The Laryngoscope.

[29]  J. Califano,et al.  Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenon , 2008, Head & neck.

[30]  C. Grau,et al.  Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study , 2008, Head & neck.

[31]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[32]  A. Garden,et al.  TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. , 2007, The Lancet. Oncology.

[33]  Alexios Martin,et al.  Twenty-five years experience with laser surgery for head and neck tumors , 2007, European Archives of Oto-Rhino-Laryngology.

[34]  E. Choi,et al.  HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c‐myc during tumor formation , 2007, International journal of cancer.

[35]  W. Westra,et al.  Detection of Human Papillomavirus-16 in Fine-Needle Aspirates to Determine Tumor Origin in Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck , 2007, Clinical Cancer Research.

[36]  G. Weinstein,et al.  Assessment of Intraoperative Safety in Transoral Robotic Surgery , 2006, The Laryngoscope.

[37]  C. Barker,et al.  Larynx-Sparing Radiotherapy for Squamous Cell Carcinoma From an Unknown Head and Neck Primary Site , 2005, American journal of clinical oncology.

[38]  Yuji Nakamoto,et al.  Normal FDG distribution patterns in the head and neck: PET/CT evaluation. , 2005, Radiology.

[39]  Kyle E. Rusthoven,et al.  The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor , 2004, Cancer.

[40]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[41]  A. Garden,et al.  Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? , 2004, Cancer.

[42]  G. Poissonnet,et al.  T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[43]  J. Ensley,et al.  An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  S. Stringer,et al.  Squamous cell carcinoma of the oropharynx , 2002, Cancer.

[45]  A. Rao,et al.  Metastatic squamous cell carcinoma of the neck from an unknown primary: Management options and patterns of relapse , 2002, Head & neck.

[46]  A. Mäkitie,et al.  Cervical Metastasis of Unknown Origin: A Series of 72 Patients , 2002, Acta oto-laryngologica.

[47]  L. Kowalski,et al.  Results of salvage treatment of the neck in patients with oral cancer. , 2002, Archives of otolaryngology--head & neck surgery.

[48]  Fei Liu,et al.  The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. , 2001, International journal of radiation oncology, biology, physics.

[49]  M. Lehtinen,et al.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.

[50]  D. Eisele,et al.  Oncologic Rationale for Bilateral Tonsillectomy in Head and Neck Squamous Cell Carcinoma of Unknown Primary Source , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[51]  Enepekides Dj Management of congenital anomalies of the neck. , 2001 .

[52]  Wen-ying Lee,et al.  Epstein‐Barr virus detection in neck metastases by in‐situ hybridization in fine‐needle aspiration cytologic studies: An aid for differentiating the primary site , 2000, Head and Neck.

[53]  C. Grau,et al.  Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  A. Garden,et al.  Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: Outcomes and patterns of failure , 1998, Head & neck.

[55]  S. P. Reddy,et al.  Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. , 1997, International journal of radiation oncology, biology, physics.

[56]  L. Peters,et al.  The occult head and neck primary: to treat or not to treat? , 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).

[57]  P. Goodman,et al.  Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  A. Shaha The Unknown Primary , 1995 .

[59]  W. Mendenhall,et al.  Squamous carcinoma presenting as an enlarged cervical lymph node , 1993, Cancer.

[60]  L. Hutchins,et al.  Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  D. Schaid,et al.  Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. , 1992, International journal of radiation oncology, biology, physics.

[62]  H. Goepfert,et al.  Unknown primary squamous cell carcinoma metastatic to the neck. , 1990, Archives of otolaryngology--head & neck surgery.

[63]  J. Fredrickson,et al.  Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries. , 1990, International journal of radiation oncology, biology, physics.

[64]  R. Glynne-Jones,et al.  Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. , 1990, International journal of radiation oncology, biology, physics.

[65]  H. Harnsberger,et al.  Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. , 1984, Radiology.

[66]  R. G. Chambers,et al.  Metastases to lymph nodes of the head and neck from an unknown primary site. , 1977, American journal of surgery.

[67]  G. Fletcher,et al.  Cervical lymph node metastasis: Unknown primary cancer , 1973, Cancer.